LifeMD (LFMD) Current Deferred Revenue (2018 - 2026)

LifeMD (LFMD) has reported Current Deferred Revenue for 9 consecutive years, with $10.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Deferred Revenue fell 36.11% year-over-year to $10.8 million; the trailing twelve-month figure through Jun 2026 stood at $10.8 million (down 36.11% YoY), and the FY2025 full-year result was $10.8 million, down 36.84% from the prior year.
• Current Deferred Revenue declined to $10.8 million in Q2 2026 per LFMD's latest filing, from $12.0 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $20.6 million in Q3 2024 and bottomed at $1.8 million in Q1 2022.
• Historically, Current Deferred Revenue has averaged $10.3 million across 5 years, with a median of $10.8 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue surged 269.86% in 2022, then tumbled 36.84% in 2025.
• Over 5 years, Current Deferred Revenue stood at $5.5 million in 2022, then soared by 31.08% to $7.3 million in 2023, then soared by 135.16% to $17.1 million in 2024, then tumbled by 36.84% to $10.8 million in 2025, then changed by 0.0% to $10.8 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $10.8 million, $12.0 million, and $10.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.